FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3204305905> ?p ?o ?g. }

• W3204305905 endingPage "941" @default.
• W3204305905 startingPage "936" @default.
• W3204305905 abstract "The N-methyl-d-aspartate receptor (NMDAR) plays a crucial role in neurodegenerative diseases such as Alzheimer disease and in the treatment of major depression by fast-acting antidepressants such as ketamine. Given their broad implications, GluN2B-containing NMDARs have been of interest as diagnostic and therapeutic targets. Recently, (R)-11C-Me-NB1 was investigated preclinically and shown to be a promising radioligand for imaging GluN2B subunits. Here, we report on the performance characteristics of this radioligand in a first-in-humans PET study. Methods: Six healthy male subjects were scanned twice on a fully integrated PET/MR scanner with (R)-11C-Me-NB1 for 120 min. Brain uptake and tracer distribution over time were investigated by SUVs. Test-retest reliability was assessed with the absolute percentage difference and the coefficient of variation. Exploratory total volumes of distribution (VT) were computed using an arterial input function and the Logan plot as well as a constrained 2-tissue-compartment model with the ratio of rate constants between plasma and tissue compartments (K1/k2) coupled (2TCM). SUV was correlated with VT to investigate its potential as a surrogate marker of GluN2B expression. Results: High and heterogeneous radioligand uptake was observed across the entire gray matter with reversible kinetics within the scan time. SUV absolute percentage difference ranged from 6.9% to 8.5% and coefficient of variation from 4.9% to 6.0%, indicating a high test-retest reliability. A moderate correlation was found between SUV averaged from 70 to 90 min and VT using Logan plot (Spearman ρ = 0.44). Correlation between VT Logan and 2TCM was r = 0.76. Conclusion: The radioligand (R)-11C-Me-NB1 was highly effective in mapping GluN2B-enriched NMDARs in the human brain. With a heterogeneous uptake and a high test-retest reliability, this radioligand offers promise to deepen our understanding of the GluN2B-containing NMDAR in the pathophysiology and treatment of neuropsychiatric disease such as Alzheimer disease and major depression. Additionally, it could help in the selection of appropriate doses of GluN2B-targeting drugs." @default.
• W3204305905 created "2021-10-11" @default.
• W3204305905 creator A5000308568 @default.
• W3204305905 creator A5018021326 @default.
• W3204305905 creator A5023419818 @default.
• W3204305905 creator A5024178731 @default.
• W3204305905 creator A5025247342 @default.
• W3204305905 creator A5031832723 @default.
• W3204305905 creator A5032669789 @default.
• W3204305905 creator A5040688269 @default.
• W3204305905 creator A5041743198 @default.
• W3204305905 creator A5043061870 @default.
• W3204305905 creator A5044226143 @default.
• W3204305905 creator A5046807922 @default.
• W3204305905 creator A5047331691 @default.
• W3204305905 creator A5048708393 @default.
• W3204305905 creator A5057349369 @default.
• W3204305905 creator A5061241787 @default.
• W3204305905 creator A5065725115 @default.
• W3204305905 creator A5067862521 @default.
• W3204305905 creator A5073649949 @default.
• W3204305905 creator A5077330365 @default.
• W3204305905 creator A5078162714 @default.
• W3204305905 creator A5078486787 @default.
• W3204305905 date "2021-10-07" @default.
• W3204305905 modified "2023-09-27" @default.
• W3204305905 title "First-in-Humans Brain PET Imaging of the GluN2B-Containing <i>N</i>-methyl-d-aspartate Receptor with (<i>R</i>)-¹¹C-Me-NB1" @default.
• W3204305905 cites W1641285430 @default.
• W3204305905 cites W1966556202 @default.
• W3204305905 cites W1990964098 @default.
• W3204305905 cites W1992177920 @default.
• W3204305905 cites W2015897296 @default.
• W3204305905 cites W2023111542 @default.
• W3204305905 cites W2047397795 @default.
• W3204305905 cites W2049511526 @default.
• W3204305905 cites W2049546272 @default.
• W3204305905 cites W2088396538 @default.
• W3204305905 cites W2095159395 @default.
• W3204305905 cites W2108596837 @default.
• W3204305905 cites W2124134368 @default.
• W3204305905 cites W2140899588 @default.
• W3204305905 cites W2160254545 @default.
• W3204305905 cites W2208668986 @default.
• W3204305905 cites W2517763372 @default.
• W3204305905 cites W2767649116 @default.
• W3204305905 cites W2773333024 @default.
• W3204305905 cites W2810491645 @default.
• W3204305905 cites W2913198853 @default.
• W3204305905 cites W2913968632 @default.
• W3204305905 cites W2939714463 @default.
• W3204305905 cites W2982646845 @default.
• W3204305905 cites W3046912008 @default.
• W3204305905 cites W3085708453 @default.
• W3204305905 doi "https://doi.org/10.2967/jnumed.121.262427" @default.
• W3204305905 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34620732" @default.
• W3204305905 hasPublicationYear "2021" @default.
• W3204305905 type Work @default.
• W3204305905 sameAs 3204305905 @default.
• W3204305905 citedByCount "13" @default.
• W3204305905 countsByYear W32043059052021 @default.
• W3204305905 countsByYear W32043059052022 @default.
• W3204305905 countsByYear W32043059052023 @default.
• W3204305905 crossrefType "journal-article" @default.
• W3204305905 hasAuthorship W3204305905A5000308568 @default.
• W3204305905 hasAuthorship W3204305905A5018021326 @default.
• W3204305905 hasAuthorship W3204305905A5023419818 @default.
• W3204305905 hasAuthorship W3204305905A5024178731 @default.
• W3204305905 hasAuthorship W3204305905A5025247342 @default.
• W3204305905 hasAuthorship W3204305905A5031832723 @default.
• W3204305905 hasAuthorship W3204305905A5032669789 @default.
• W3204305905 hasAuthorship W3204305905A5040688269 @default.
• W3204305905 hasAuthorship W3204305905A5041743198 @default.
• W3204305905 hasAuthorship W3204305905A5043061870 @default.
• W3204305905 hasAuthorship W3204305905A5044226143 @default.
• W3204305905 hasAuthorship W3204305905A5046807922 @default.
• W3204305905 hasAuthorship W3204305905A5047331691 @default.
• W3204305905 hasAuthorship W3204305905A5048708393 @default.
• W3204305905 hasAuthorship W3204305905A5057349369 @default.
• W3204305905 hasAuthorship W3204305905A5061241787 @default.
• W3204305905 hasAuthorship W3204305905A5065725115 @default.
• W3204305905 hasAuthorship W3204305905A5067862521 @default.
• W3204305905 hasAuthorship W3204305905A5073649949 @default.
• W3204305905 hasAuthorship W3204305905A5077330365 @default.
• W3204305905 hasAuthorship W3204305905A5078162714 @default.
• W3204305905 hasAuthorship W3204305905A5078486787 @default.
• W3204305905 hasBestOaLocation W32043059051 @default.
• W3204305905 hasConcept C126322002 @default.
• W3204305905 hasConcept C170493617 @default.
• W3204305905 hasConcept C185592680 @default.
• W3204305905 hasConcept C199374082 @default.
• W3204305905 hasConcept C2775842073 @default.
• W3204305905 hasConcept C2989005 @default.
• W3204305905 hasConcept C43617362 @default.
• W3204305905 hasConcept C60592354 @default.
• W3204305905 hasConcept C67018056 @default.
• W3204305905 hasConcept C67847695 @default.
• W3204305905 hasConcept C71924100 @default.
• W3204305905 hasConcept C89838059 @default.

• next